Investment analysts at HC Wainwright began coverage on shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) in a report issued on Monday. The firm set a “buy” rating and a $4.00 price target on the medical technology company’s stock. HC Wainwright’s price objective would suggest a potential upside of 138.11% from the company’s current price.

Shares of Alphatec Holdings (ATEC) opened at 1.6799 on Monday. The stock has a 50 day moving average price of $1.74 and a 200-day moving average price of $2.33. Alphatec Holdings has a 52 week low of $1.58 and a 52 week high of $9.65.

Alphatec Holdings (NASDAQ:ATEC) last announced its quarterly earnings results on Thursday, August 10th. The medical technology company reported ($0.32) earnings per share (EPS) for the quarter. The company had revenue of $24.38 million during the quarter. On average, equities research analysts predict that Alphatec Holdings will post ($1.20) EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Alphatec Holdings, Inc. (NASDAQ:ATEC) Receives New Coverage from Analysts at HC Wainwright” was first published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.dailypolitical.com/2017/08/14/alphatec-holdings-inc-nasdaqatec-receives-new-coverage-from-analysts-at-hc-wainwright.html.

A hedge fund recently raised its stake in Alphatec Holdings stock. Renaissance Technologies LLC increased its stake in shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) by 85.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 313,545 shares of the medical technology company’s stock after buying an additional 144,300 shares during the period. Renaissance Technologies LLC’s holdings in Alphatec Holdings were worth $1,006,000 as of its most recent filing with the SEC. 20.69% of the stock is currently owned by hedge funds and other institutional investors.

About Alphatec Holdings

Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.

Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.